Recent developments center on an unconfirmed October 2026 laboratory-associated pneumonia case in Irkutsk, Russia, where authorities reported no Yersinia pestis detection among the worker or nearly 200 contacts after enhanced monitoring. WHO assessments classified international risk as very low, with no evidence of sustained person-to-person transmission or clusters meeting International Health Regulations thresholds for a Public Health Emergency of International Concern. Endemic foci continue to produce sporadic cases in the Democratic Republic of the Congo, Madagascar, and the United States, yet surveillance data show no exponential growth or cross-border escalation. Trader consensus prices a qualifying declaration by late 2026 at minimal levels, reflecting routine antibiotic treatment, contact tracing, and the absence of new catalysts that would alter these containment dynamics before year-end resolution.
Experimental AI-generated summary referencing Polymarket data. This is not trading advice and plays no role in how this market resolves. · Updated1H6H1D7D30DALL
View resolved

Beware of external links.
Beware of external links.
Frequently Asked Questions